oasis 1 trial semaglutide Efficacy of Oral Semaglutide: Overview of the PIONEER Clinical Trial Program and Implications for Managed Care The first GLP-1 weight-loss pill:

Among these, sodium-glucose co-transporter 2 inhibitors (SGLT2-Is) and GLP-1RAs proved to have several vascular actions going beyond simple antihyperglycemic effects

Once the first dose is drawn from a vial or the first injection given from a pen, the in-use period begins

While these effects may be beneficial in selected cardiovascular indications, they raised concerns regarding hypotension and hemodynamic instability when considered for chronic metabolic disease

Reduced gallbladder motility

Despite the burgeoning literature on the safety and efficacy of GLP-1 RAs, existing systematic reviews and meta-analyses predominantly focus on populations with T2DM, where gastrointestinal symptoms may be confounded by the underlying disease pathology [7]

\Safety Profile: Mild, transient side effects